ProfileGDS4814 / ILMN_1728514
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 89% 89% 88% 88% 89% 89% 88% 88% 89% 88% 88% 88% 89% 88% 89% 87% 88% 87% 88% 89% 89% 88% 89% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)365.44989
GSM780708Untreated after 4 days (C2_1)351.06989
GSM780709Untreated after 4 days (C3_1)333.17888
GSM780719Untreated after 4 days (C1_2)303.56488
GSM780720Untreated after 4 days (C2_2)346.51789
GSM780721Untreated after 4 days (C3_2)373.49789
GSM780710Trastuzumab treated after 4 days (T1_1)340.21988
GSM780711Trastuzumab treated after 4 days (T2_1)338.7688
GSM780712Trastuzumab treated after 4 days (T3_1)353.96989
GSM780722Trastuzumab treated after 4 days (T1_2)321.8988
GSM780723Trastuzumab treated after 4 days (T2_2)325.60488
GSM780724Trastuzumab treated after 4 days (T3_2)320.67188
GSM780713Pertuzumab treated after 4 days (P1_1)372.02889
GSM780714Pertuzumab treated after 4 days (P2_1)318.60188
GSM780715Pertuzumab treated after 4 days (P3_1)346.21389
GSM780725Pertuzumab treated after 4 days (P1_2)293.72687
GSM780726Pertuzumab treated after 4 days (P2_2)322.79588
GSM780727Pertuzumab treated after 4 days (P3_2)281.2387
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)333.24588
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)362.88289
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)365.82989
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)325.19288
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)344.9989